Holista Colltech (ASX:HCT) has secured the exclusive rights for the Geltox Skin Science formulation that provides immediate short term reduction in facial expression lines as well as wrinkles.
This also reduces the appearance of these lines over the course of several months while eliminating the need for injections by a qualified professional.
Geltox Skin Science uses a combination of peptides and muscle relaxers that deeply penetrate skin and cause mild paralysis in select areas of the face similar to injections like Botox.
The technology is patent pending and was developed by Palma Biotech.
Holista will take the formulation into the Asian Pacific region.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.